Two HLA class I alleles are independently associated with an increased risk for allopurinol-induced severe cutaneous adverse reactions.

There was an increase in the hepatic fat fraction, the long-term consequences of which are unknown, says Robert Rosenson.

Statistically significant and clinically meaningful improvements in mean ACQ-5 scores were reported at week 16 versus placebo ...

Novel combination with neoadjuvant eftilagimod alfa (efti) achieves significant 51.5% tumour hyalinization/fibrosis across multiple soft tissue ...

Monthly olezarsen reduced triglycerides by 65% for people with severe hypertriglyceridemia, resulting in a greater than 85% ...

Which assets offer the strongest potential for early buyers reviewing PepePawn, SHHEIKH, Tapzi, Zephyr, Ionix Chain, and ...

Alkermes reports positive results from Vibrance-2 phase 2 study of once-daily alixorexton in patients with narcolepsy type 2: Dublin Friday, November 14, 2025, 18:00 Hrs [IST] Alk ...

The study presents important insights into the regulation of muscle hypertrophy, regulated by Muscle Ankyrin Repeat Proteins (MARPs) and mTOR. The methods are overall solid and complementary, with ...

Alkermes plc (Nasdaq: ALKS) today announced positive topline results from the Vibrance-2 dose-ranging phase 2 study evaluating alixorexton in patients with narcolepsy type 2 (NT2). Alixorexton, ...

Q3 2025 Earnings Call November 13, 2025 8:30 AM ESTCompany ParticipantsJack Garman - Vice President of Investor ...

Lincoln Educational Services Corporation (LINC) faces margin compression and disappointing profitability despite strong ...